All Stories

  1. Intensive Care Unit Admission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Is It Necessary?

    Article • Journal of Oncology, January 2014, Hindawi Publishing Corporation

    FLAVIA MORALES

  2. Weekly Low-doses with Prolonged Infusion of Gemcitabine /Cisplatin for Multi-treated Metastatic Breast Cancer Patients

    Article • Current Cancer Therapy Reviews, August 2013, Bentham Science Publishers

    FLAVIA MORALES

  3. Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?

    Article • Cancer Management and Research, April 2013, Taylor & Francis

    FLAVIA MORALES

  4. Chemotherapy in Inflammatory Breast Cancer

    Article • September 2012, Springer Science + Business Media

    FLAVIA MORALES

  5. Follow-Up in Inflammatory Breast Cancer

    Article • September 2012, Springer Science + Business Media

    FLAVIA MORALES

  6. Target Therapy in Inflammatory Breast Cancer

    Article • September 2012, Springer Science + Business Media

    FLAVIA MORALES

  7. Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico

    Article • ISRN Oncology, August 2011, Hindawi Publishing Corporation

    FLAVIA MORALES

  8. Phase II Study of Neo-adjuvant Gemcitabine Plus Epirubicin in Primarily Unresectable Locally Advanced Breast Cancer

    Article • The Breast Journal, July 2008, Hindawi Publishing Corporation

    FLAVIA MORALES

  9. Adjuvant Chemotherapy with Doxorubicin and Dacarbazine has No Effect in Recurrence-Free Survival of Malignant Phyllodes Tumors of the Breast

    Article • The Breast Journal, October 2007, Hindawi Publishing Corporation

    FLAVIA MORALES

  10. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

    Article • The Lancet Oncology, March 2007, Elsevier

    FLAVIA MORALES

  11. Overview of Resistance to Systemic Therapy in Patients with Breast Cancer

    Article • January 2007, Springer Science + Business Media

    FLAVIA MORALES

  12. Downregulation of the Cyclin-Dependent Kinase Inhibitor p27kip1 Might Correlate with Poor Disease-Free and Overall Survival in Inflammatory Breast Cancer

    Article • Clinical Breast Cancer, October 2006, Elsevier

    FLAVIA MORALES

  13. Ocular Metastases from Breast Carcinoma

    Article • Medical Oncology, January 2004, Springer Science + Business Media

    FLAVIA MORALES